I. I
Acyclovir is the Active Pharmaceutical Ingredient (API) in the most common antiviral drug used for treatment of HSV and VZV infections. Advantages for acyclovir are low cytotoxicity and low HSV resistance as well as the availability of low cost generic forms. Disadvantages are low bioavailability, perhaps partially due to low solubility and lower effectiveness than valacyclovir, famciclovir, and fascarnet for HSV infection. As with many viral diseases, after several decades of acyclovir use, resistant strains of the virus are beginning to develop, especially in immunocompromised patients [1] .
The combinations of acyclovir with other compounds, some of these demonstrated antiviral activity and have been demonstrated to possess synergistic effects against HSV. Bioavailability of acyclovir after oral and intravenous administration of its conjugate with PHEA is higher than following administration of free acyclovir [2] , [3] . Complexation between acyclovir (ACV) with β-cyclodextrin (β-CD) (1:1) used for the treatment of herpes simplex virus infection was found much more soluble than the uncomplexed drug [4] . The natural substances and dietary modifications such as lysine,  Manuscript received April 10, 2015; revised July 4, 2016.
vitamin C, zinc, vitamin E, adenosine monophosphate, lemon balm, and lithium useful for treating HSV lesions or preventing recurrences [4] . For vitamin C, massive parenteral doses of vitamin C accelerate the healing of herpes lesions [4] , [5] . While Zinc was inhibition was almost complete and appears to result from selective inhibition of the viral DNA polymerase of HSV-1 and HSV-2 in vitro and, reduces the frequency and severity of herpes outbreaks.
This research focused on ascorbic acid (vitamin C) and Zinc chloride forming a new complex with potentially improved solubility of the acyclovir drug, or a possibly synergistic material useful for HSV/VZV treatment and may reduce the frequency and severity of herpes outbreaks.
II. MATERIALS AND METHODS
All chemicals were reagent grade and were used without further purification. FT-infrared spectra were measured on Spectrum GX, over the range 4000-400 cm 
A. Separation of Acyclovir
Acyclovir material was separated from an acyclovir drug, (Vilerm, Siam Pharmaceutical Co., containing 800 mg acyclovir in a 1,032 mg tablet) with 320 mL of deionized H 2 O; solubility in water (2.5 mg/mL at 37°C), stirred at 250 rpm and heated at 70-80°C for 30 mins and filtered. The filtrate was heated at 70-80°C to reduce the volume until one third remained, cooled to room temperature, and left overnight to precipitate. The precipitate was filtered, washed with distilled H 2 O, and dried in air at room temperature (recovery: 33.5% based on acyclovir) [6] .
B. Cocrystal Screening by Solution-Based Methods
The crystallization of acyclovir with ascorbic acid and zinc chloride 1:1:1 weight ratio into 10 solvents (0.5 M HCl, 0.1 M HCl, water, acetic acid-water (1:1), ethyl acetate-water (1:1), isopropanol-water (1:2), DMSOwater (1:1), ethanol-water (1:2), ethanol-DMSO (1:1), methanol-DMSO (1:1). The mixture was heat at 70-80 o C and stirred 300 rpm for 30 minutes to obtain a clear solution and filtrated. The filtrate was cool at room temperature for several days.
III. RESULTS AND DISCUSSION

A. Cocrysal Screening
Cocrystal screening conditions of the 1:1:1 molar ratio acyclovir (ACV): ascorbic acid (As): zinc chloride (Zn) under 10 solvents as 0.5 M HCl, 0.1M HCl, water, acetic acid-water (1:1), ethyl acetate-water (1:1), isopropanolwater (1:2), DMSO-water (1:1), ethanol-water (1:2), ethanol-DMSO (1:1), and methanol-DMSO (1:1) shown in Table I . Yellow-brown thin-plate shaped cocrystals of ACV-ASc-Zn (6) was obtained from the mixed solvents (isopropanol:water), for about 60% of yields (see Fig. 1 ). The crystal morphology and chemical compositions of the product compound are shown in Fig. 2 by SEM image and EDX elemental analysis. The pyramidal-plate like crystals obtained (see Fig. 2a ) and EDX results presented Zn and Cl spectra containing in the compound (see Fig.  2b ). 
B. FT-IR Spectra of ACV-ASc-Zn
FT-IR wavenumbers, Intensities and spectral band assignment is presented in Table II , spectral band assignments based on the literature and database of acyclovir [7] - [8] . Fig. 3 shows the infrared spectra of ), is belonging to the monodentate carboxylate binding mode to the zinc (II) atom [9] . 
C. Thermogravimetric Analysis of ACV-ASc-Zn (6)
TGA and DTG curves of the zinc complex, 1:1:1 ACV-ASc-Zn (6) are shown in Fig. 4 . The decomposed and produced Zn as residue is about 42.68% into four steps. The 1:1:1 ACV-ASc-Zn (6) 
